{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:11:51Z","timestamp":1707523911728},"reference-count":45,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,21]]},"DOI":"10.7759\/cureus.49197","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T21:37:29Z","timestamp":1700602649000},"source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological Management for Pediatric Irritable Bowel Syndrome: A Review"],"prefix":"10.7759","author":[{"given":"Alaa S","family":"Alyasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A","family":"Altawili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa F","family":"Alabbadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma Hussain A","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amjad S","family":"Alshammery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed I","family":"Alfahad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahaf M","family":"Alamri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talal R","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maram Hafiz A","family":"Harbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa M","family":"Alajmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jehad M","family":"Alabdulrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani M","family":"Alalshaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afnan M","family":"Hanbzazah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1622","article-title":"Irritable bowel syndrome: new and emerging treatments","volume":"18","author":"Halland M","year":"2015","unstructured":"Halland M, Saito YA. Irritable bowel syndrome: new and emerging treatments. BMJ. 2015, 18:1622. 10.1136\/bmj.h1622","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6110099","article-title":"Rome criteria and a diagnostic approach to irritable bowel syndrome","volume":"6","author":"Lacy BE","year":"2017","unstructured":"Lacy BE, Patel NK. Rome criteria and a diagnostic approach to irritable bowel syndrome. J Clin Med. 2017, 6:99. 10.3390\/jcm6110099","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126982","article-title":"Epidemiology of pediatric functional abdominal pain disorders: a meta-analysis","volume":"10","author":"Korterink JJ","year":"2015","unstructured":"Korterink JJ, Diederen K, Benninga MA, Tabbers MM. Epidemiology of pediatric functional abdominal pain disorders: a meta-analysis. PLoS One. 2015, 10:e0126982. 10.1371\/journal.pone.0126982","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.015","article-title":"Functional disorders: children and adolescents","author":"Hyams JS","year":"2016","unstructured":"Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Functional disorders: children and adolescents. Gastroenterology. 2016, 10.1053\/j.gastro.2016.02.015","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i34.12144","article-title":"Irritable bowel syndrome: a clinical review","volume":"20","author":"Soares RL","year":"2014","unstructured":"Soares RL. Irritable bowel syndrome: a clinical review. World J Gastroenterol. 2014, 20:12144-60. 10.3748\/wjg.v20.i34.12144","journal-title":"World J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4166\/kjg.2022.014","article-title":"Efficacy of a restrictive diet in irritable bowel syndrome: a systematic review and network meta-analysis","volume":"80","author":"Yu SJ","year":"2022","unstructured":"Yu SJ, Lee HS, Gung HJ, et al.. Efficacy of a restrictive diet in irritable bowel syndrome: a systematic review and network meta-analysis. Korean J Gastroenterol. 2022, 80:6-16. 10.4166\/kjg.2022.014","journal-title":"Korean J Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S174982","article-title":"The role of inflammation in irritable bowel syndrome (IBS)","volume":"11","author":"Ng QX","year":"2018","unstructured":"Ng QX, Soh AY, Loke W, Lim DY, Yeo WS. The role of inflammation in irritable bowel syndrome (IBS). J Inflamm Res. 2018, 11:345-9. 10.2147\/JIR.S174982","journal-title":"J Inflamm Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31823d34c3","article-title":"Brain-gut axis: from basic understanding to treatment of IBS and related disorders","volume":"54","author":"Camilleri M","year":"2012","unstructured":"Camilleri M, Di Lorenzo C. Brain-gut axis: from basic understanding to treatment of IBS and related disorders. J Pediatr Gastroenterol Nutr. 2012, 54:446-53. 10.1097\/MPG.0b013e31823d34c3","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-017-1445-8","article-title":"Gut microbiota functions: metabolism of nutrients and other food components","volume":"57","author":"Rowland I","year":"2018","unstructured":"Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, Tuohy K. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr. 2018, 57:1-24. 10.1007\/s00394-017-1445-8","journal-title":"Eur J Nutr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.866059","article-title":"The role of diet and gut microbiota in regulating gastrointestinal and inflammatory disease","volume":"13","author":"Gill PA","year":"2022","unstructured":"Gill PA, Inniss S, Kumagai T, Rahman FZ, Smith AM. The role of diet and gut microbiota in regulating gastrointestinal and inflammatory disease. Front Immunol. 2022, 13:866059. 10.3389\/fimmu.2022.866059","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3928\/00904481-20140325-08","article-title":"Pediatric IBS: an overview on pathophysiology, diagnosis and treatment","volume":"43","author":"Chogle A","year":"2014","unstructured":"Chogle A, Mintjens S, Saps M. Pediatric IBS: an overview on pathophysiology, diagnosis and treatment. Pediatr Ann. 2014, 43:e76-82. 10.3928\/00904481-20140325-08","journal-title":"Pediatr Ann"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2023.2242775","article-title":"Managing pain in irritable bowel syndrome: current perspectives and best practice","volume":"17","author":"Algera J","year":"2023","unstructured":"Algera J, L\u00f6vdahl J, Sj\u00f6lund J, Tornkvist NT, T\u00f6rnblom H. Managing pain in irritable bowel syndrome: current perspectives and best practice. Expert Rev Gastroenterol Hepatol. 2023, 17:871-81. 10.1080\/17474124.2023.2242775","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3244-x","article-title":"Metabolic kinetics of 5-hydroxytryptamine and the research targets of functional gastrointestinal disorders","volume":"59","author":"Jing F","year":"2014","unstructured":"Jing F, Zhang J. Metabolic kinetics of 5-hydroxytryptamine and the research targets of functional gastrointestinal disorders. Dig Dis Sci. 2014, 59:2642-8. 10.1007\/s10620-014-3244-x","journal-title":"Dig Dis Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.817100","article-title":"Neurotransmitter and intestinal interactions: focus on the microbiota-gut-brain axis in irritable bowel syndrome","volume":"13","author":"Chen M","year":"2022","unstructured":"Chen M, Ruan G, Chen L, et al.. Neurotransmitter and intestinal interactions: focus on the microbiota-gut-brain axis in irritable bowel syndrome. Front Endocrinol (Lausanne). 2022, 13:817100. 10.3389\/fendo.2022.817100","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7297","article-title":"Expression and clinical significance of 5-HT and 5-HT(3)R in the intestinal mucosa of patient with diarrhea-type irritable bowel syndrome","volume":"17","author":"Fu R","year":"2019","unstructured":"Fu R, Chen M, Chen Y, Mao G, Liu S. Expression and clinical significance of 5-HT and 5-HT(3)R in the intestinal mucosa of patient with diarrhea-type irritable bowel syndrome. Exp Ther Med. 2019, 17:3077-82. 10.3892\/etm.2019.7297","journal-title":"Exp Ther Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5056\/jnm16155","article-title":"Neuroendocrine dysregulation in irritable bowel syndrome patients: a pilot study","volume":"23","author":"Stasi C","year":"2017","unstructured":"Stasi C, Bellini M, Gambaccini D, et al.. Neuroendocrine dysregulation in irritable bowel syndrome patients: a pilot study. J Neurogastroenterol Motil. 2017, 23:428-34. 10.5056\/jnm16155","journal-title":"J Neurogastroenterol Motil"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1207068","article-title":"Peripheral mechanisms in irritable bowel syndrome","volume":"367","author":"Camilleri M","year":"2012","unstructured":"Camilleri M. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med. 2012, 367:1626-35. 10.1056\/NEJMra1207068","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.suppl_2.ii1","article-title":"British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome","volume":"47 Suppl 2","author":"Jones J","year":"2000","unstructured":"Jones J, Boorman J, Cann P, et al.. British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut. 2000, 47 Suppl 2:ii1-19. 10.1136\/gut.47.suppl_2.ii1","journal-title":"Gut"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3928\/00904481-20151208-01","article-title":"Irritable bowel syndrome: a review for general pediatricians","volume":"45","author":"Kridler J","year":"2016","unstructured":"Kridler J, Kamat D. Irritable bowel syndrome: a review for general pediatricians. Pediatr Ann. 2016, 45:e30-3. 10.3928\/00904481-20151208-01","journal-title":"Pediatr Ann"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.34755","article-title":"Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease","volume":"123","author":"Tibble JA","year":"2002","unstructured":"Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology. 2002, 123:450-60. 10.1053\/gast.2002.34755","journal-title":"Gastroenterology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2008.ii43","article-title":"Functional bowel disorders and functional abdominal pain","volume":"45","author":"Thompson W","year":"1999","unstructured":"Thompson W, Longstreth G, Drossman D, Heaton K, Irvine E, Muller-Lissner S. Functional bowel disorders and functional abdominal pain. Gut. 1999, 45:II43-7. 10.1136\/gut.45.2008.ii43","journal-title":"Gut"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.08.048","article-title":"Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care","volume":"145","author":"Ford AC","year":"2013","unstructured":"Ford AC, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology. 2013, 145:1262-70.e1. 10.1053\/j.gastro.2013.08.048","journal-title":"Gastroenterology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.014","article-title":"Rome IV diagnostic questionnaires and tables for investigators and clinicians","author":"Palsson OS","year":"2016","unstructured":"Palsson OS, Whitehead WE, van Tilburg MA, et al.. Rome IV diagnostic questionnaires and tables for investigators and clinicians. Gastroenterology. 2016, 10.1053\/j.gastro.2016.02.014","journal-title":"Gastroenterology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000003622","article-title":"Efficacy of oral psyllium in pediatric irritable bowel syndrome: a double-blind randomized control trial","volume":"76","author":"Menon J","year":"2023","unstructured":"Menon J, Thapa BR, Kumari R, Puttaiah Kadyada S, Rana S, Lal SB. Efficacy of oral psyllium in pediatric irritable bowel syndrome: a double-blind randomized control trial. J Pediatr Gastroenterol Nutr. 2023, 76:14-9. 10.1097\/MPG.0000000000003622","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.09.026","article-title":"Adolescent growth spurts in female gymnasts","volume":"146","author":"Thomis M","year":"2005","unstructured":"Thomis M, Claessens AL, Lefevre J, Philippaerts R, Beunen GP, Malina RM. Adolescent growth spurts in female gymnasts. J Pediatr. 2005, 146:239-44. 10.1016\/j.jpeds.2004.09.026","journal-title":"J Pediatr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.03.045","article-title":"Psyllium fiber reduces abdominal pain in children with irritable bowel syndrome in a randomized, double-blind trial","volume":"15","author":"Shulman RJ","year":"2017","unstructured":"Shulman RJ, Hollister EB, Cain K, et al.. Psyllium fiber reduces abdominal pain in children with irritable bowel syndrome in a randomized, double-blind trial. Clin Gastroenterol Hepatol. 2017, 15:712-719.e4. 10.1016\/j.cgh.2016.03.045","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181ca4d95","article-title":"VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study","volume":"51","author":"Guandalini S","year":"2010","unstructured":"Guandalini S, Magazz\u00f9 G, Chiaro A, et al.. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr. 2010, 51:24-30. 10.1097\/MPG.0b013e3181ca4d95","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3920\/BM2017.0129","article-title":"Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study","volume":"9","author":"Sudha MR","year":"2018","unstructured":"Sudha MR, Jayanthi N, Aasin M, Dhanashri RD, Anirudh T. Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study. Benef Microbes. 2018, 9:563-72. 10.3920\/BM2017.0129","journal-title":"Benef Microbes"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-0467","article-title":"A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain","volume":"126","author":"Francavilla R","year":"2010","unstructured":"Francavilla R, Miniello V, Magist\u00e0 AM, et al.. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics. 2010, 126:e1445-52. 10.1542\/peds.2010-0467","journal-title":"Pediatrics"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5056\/jnm.2013.19.1.90","article-title":"The incidence of irritable bowel syndrome in children using the Rome III criteria and the effect of trimebutine treatment","volume":"19","author":"Karabulut GS","year":"2013","unstructured":"Karabulut GS, Be\u015fer OF, Ergin\u00f6z E, Kutlu T, Coku\u011fra\u015f F\u00c7, Erkan T. The incidence of irritable bowel syndrome in children using the Rome III criteria and the effect of trimebutine treatment. J Neurogastroenterol Motil. 2013, 19:90-3. 10.5056\/jnm.2013.19.1.90","journal-title":"J Neurogastroenterol Motil"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3109\/19390211.2010.486702","article-title":"An evidence-based systematic review of spearmint by the natural standard research collaboration","volume":"7","author":"Ulbricht C","year":"2010","unstructured":"Ulbricht C, Costa D, M Grimes Serrano J, Guilford J, Isaac R, Seamon E, Varghese M. An evidence-based systematic review of spearmint by the natural standard research collaboration. J Diet Suppl. 2010, 7:179-215. 10.3109\/19390211.2010.486702","journal-title":"J Diet Suppl"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2004.10.006","article-title":"Gastrointestinal clinical pharmacology of peppermint oil","volume":"12","author":"Grigoleit HG","year":"2005","unstructured":"Grigoleit HG, Grigoleit P. Gastrointestinal clinical pharmacology of peppermint oil. Phytomedicine. 2005, 12:607-11. 10.1016\/j.phymed.2004.10.006","journal-title":"Phytomedicine"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1099-1573(200002)14:1<20::aid-ptr542>3.0.co;2-z","article-title":"Effects of peppermint oil and caraway oil on gastroduodenal motility","volume":"14","author":"Micklefield GH","year":"2000","unstructured":"Micklefield GH, Greving I, May B. Effects of peppermint oil and caraway oil on gastroduodenal motility. Phytother Res. 2000, 14:20-3. 10.1002\/(sici)1099-1573(200002)14:1&lt;20::aid-ptr542&gt;3.0.co;2-z","journal-title":"Phytother Res"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-015-0730-y","article-title":"Efficacy and safety of drotaverine hydrochloride in children with recurrent abdominal pain: a randomized placebo controlled trial","volume":"52","author":"Narang M","year":"2015","unstructured":"Narang M, Shah D, Akhtar H. Efficacy and safety of drotaverine hydrochloride in children with recurrent abdominal pain: a randomized placebo controlled trial. Indian Pediatr. 2015, 52:847-51. 10.1007\/s13312-015-0730-y","journal-title":"Indian Pediatr"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2021.1976753","article-title":"Pharmacological interventions for pediatric irritable bowel syndrome","volume":"23","author":"Pesce M","year":"2022","unstructured":"Pesce M, Puoti MG, Rybak A, Andreozzi M, Bruzzese E, Sarnelli G, Borrelli O. Pharmacological interventions for pediatric irritable bowel syndrome. Expert Opin Pharmacother. 2022, 23:91-103. 10.1080\/14656566.2021.1976753","journal-title":"Expert Opin Pharmacother"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1159\/000362405","article-title":"Medication management of irritable bowel syndrome","volume":"89","author":"Trinkley KE","year":"2014","unstructured":"Trinkley KE, Nahata MC. Medication management of irritable bowel syndrome. Digestion. 2014, 89:253-67. 10.1159\/000362405","journal-title":"Digestion"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12444","article-title":"Citalopram for pediatric functional abdominal pain: a randomized, placebo-controlled trial","volume":"26","author":"Roohafza H","year":"2014","unstructured":"Roohafza H, Pourmoghaddas Z, Saneian H, Gholamrezaei A. Citalopram for pediatric functional abdominal pain: a randomized, placebo-controlled trial. Neurogastroenterol Motil. 2014, 26:1642-50. 10.1111\/nmo.12444","journal-title":"Neurogastroenterol Motil"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15765","article-title":"Efficacy of amitriptyline in pediatric functional abdominal pain disorders: a randomized placebo-controlled trial","volume":"37","author":"Seetharaman J","year":"2022","unstructured":"Seetharaman J, Poddar U, Yachha SK, Srivastava A, Sen Sarma M. Efficacy of amitriptyline in pediatric functional abdominal pain disorders: a randomized placebo-controlled trial. J Gastroenterol Hepatol. 2022, 37:685-91. 10.1111\/jgh.15765","journal-title":"J Gastroenterol Hepatol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.06.060","article-title":"Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders","volume":"137","author":"Saps M","year":"2009","unstructured":"Saps M, Youssef N, Miranda A, Nurko S, Hyman P, Cocjin J, Di Lorenzo C. Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology. 2009, 137:1261-9. 10.1053\/j.gastro.2009.06.060","journal-title":"Gastroenterology"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2007.10.012","article-title":"Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents","volume":"152","author":"Bahar RJ","year":"2008","unstructured":"Bahar RJ, Collins BS, Steinmetz B, Ament ME. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatr. 2008, 152:685-9. 10.1016\/j.jpeds.2007.10.012","journal-title":"J Pediatr"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.14","article-title":"Irritable bowel syndrome","volume":"2","author":"Enck P","year":"2016","unstructured":"Enck P, Aziz Q, Barbara G, et al.. Irritable bowel syndrome. Nat Rev Dis Primers. 2016, 2:16014. 10.1038\/nrdp.2016.14","journal-title":"Nat Rev Dis Primers"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01449.x","article-title":"Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects","volume":"17","author":"Coffin B","year":"2003","unstructured":"Coffin B, Farmachidi JP, Rueegg P, Bastie A, Bouhassira D. Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects. Aliment Pharmacol Ther. 2003, 17:577-85. 10.1046\/j.1365-2036.2003.01449.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpg.0000304454.99799.42","article-title":"Tegaserod use in children: a single-center experience","volume":"46","author":"Liem O","year":"2008","unstructured":"Liem O, Mousa HM, Benninga MA, Di Lorenzo C. Tegaserod use in children: a single-center experience. J Pediatr Gastroenterol Nutr. 2008, 46:54-8. 10.1097\/01.mpg.0000304454.99799.42","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3109\/00365528209182056","article-title":"The effect of variations in intragastric pressure and gastric emptying of a saline meal in humans","volume":"17","author":"Valenzuela JE","year":"1982","unstructured":"Valenzuela JE, Liu DP. The effect of variations in intragastric pressure and gastric emptying of a saline meal in humans. Scand J Gastroenterol. 1982, 17:293-6. 10.3109\/00365528209182056","journal-title":"Scand J Gastroenterol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001819","article-title":"Randomized controlled clinical trial on value of domperidone in functional abdominal pain in children","volume":"66","author":"Karunanayake A","year":"2018","unstructured":"Karunanayake A, Devanarayana NM, de Silva A, Gunawardena S, Rajindrajith S. Randomized controlled clinical trial on value of domperidone in functional abdominal pain in children. J Pediatr Gastroenterol Nutr. 2018, 66:725-31. 10.1097\/MPG.0000000000001819","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/196880-pharmacological-management-for-pediatric-irritable-bowel-syndrome-a-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:41Z","timestamp":1707508481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/196880-pharmacological-management-for-pediatric-irritable-bowel-syndrome-a-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,21]]},"references-count":45,"URL":"https:\/\/doi.org\/10.7759\/cureus.49197","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,21]]}}}